Company Filing History:
2 out of 210 
1 out of 321 
Years Active: 2017-2019
Title: Hirohiko Ise: Pioneering Innovations in Drug Delivery Systems
Introduction: Hirohiko Ise is a notable inventor based in Fukuoka, Japan, recognized for his significant contributions to the fields of drug delivery systems and biochemistry. With two patents to his name, Ise's work focuses on the development of compounds that enhance the targeting and delivery of therapeutic agents to specific cells affected by diseases.
Latest Patents: Hirohiko Ise's latest inventions include innovative compounds that aim to revolutionize drug delivery. His patent on the "N-acetylglucosamine sugar chain group-containing compound" outlines a carrier compound designed for efficient transport of drugs. This compound shows excellent affinity towards N-acetylglucosamine sugar chain-recognizing proteins, allowing it to target cells where vimentin and/or desmin proteins are exposed. The associated drug delivery system leverages a polymer with a weight average molecular weight between 15,000 and 100,000, facilitating precise medical treatments. Additionally, he has developed a "sugar chain-containing polymer" that targets liver fibrosis lesions, providing promising solutions for imaging, diagnosis, and therapies related to liver fibrosis.
Career Highlights: Hirohiko Ise has gained valuable experience working with renowned organizations throughout his career. Notable among these are Somar Corporation and the Korea Research Institute of Bioscience and Biotechnology. His innovative approach and dedication to research have influenced the ongoing development of drug delivery technologies.
Collaborations: Throughout his career, Ise has collaborated with distinguished professionals, including Bong Hyun Chung and Toshihiro Akaike. These partnerships have enriched his research endeavors and contributed to the advancement of biomedical sciences.
Conclusion: Hirohiko Ise stands out as a prominent figure in the innovation of drug delivery systems. His patents demonstrate both creativity and a commitment to addressing medical challenges. As he continues to develop groundbreaking compounds, Ise's influence in the field is expected to expand further, paving the way for new therapeutic solutions.